Couverture de GLP-1 Drugs and Kidney Disease

GLP-1 Drugs and Kidney Disease

GLP-1 Drugs and Kidney Disease

De : Inception Point Ai
Écouter gratuitement

À propos de ce contenu audio

 Discover how GLP-1 drugs like semaglutide are revolutionizing kidney disease treatment, cutting risk by 24% in landmark trials. Join host Julia Cartwright as she uncovers the science, breakthrough research, and future of kidney protection for millions with chronic kidney disease.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai
Épisodes
  • GLP-1 Drugs and Kidney Disease - Who Benefits Most and What Comes Next

    GLP-1 Drugs and Kidney Disease - Who Benefits Most and What Comes Next
    Apr 7 2026
    Join host Julia Cartwright as she explores who benefits most from GLP-1 receptor agonists in kidney disease treatment. From the groundbreaking FLOW trial results in diabetic patients to emerging research in non-diabetic kidney disease, discover what four pillars of modern kidney care mean for patients facing declining function, and what cutting-edge biopsy studies reveal about these medications' future potential.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Afficher plus Afficher moins
    22 min
  • GLP-1 Drugs and Kidney Disease - Inside the Kidney: How These Drugs Actually Work

    GLP-1 Drugs and Kidney Disease - Inside the Kidney: How These Drugs Actually Work
    Apr 7 2026
    Julia Cartwright explores how GLP-1 drugs protect kidneys through multiple pathways—reducing inflammation, scarring, and protein leakage while improving blood sugar and blood pressure. Research shows these medications lower kidney failure risk by 16% in diabetic and non-diabetic patients, offering hope beyond traditional treatments as a promising fourth pillar of kidney disease prevention.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Afficher plus Afficher moins
    29 min
  • GLP-1 Drugs and Kidney Disease - The Trial That Changed Everything

    GLP-1 Drugs and Kidney Disease - The Trial That Changed Everything
    Apr 7 2026
    Julia Cartwright explores how the FLOW trial revealed GLP-1 drugs like semaglutide offer groundbreaking kidney protection for diabetic patients, reducing kidney failure risk by 24%—results so powerful the study stopped early, establishing a fourth pillar in chronic kidney disease treatment alongside existing therapies.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Afficher plus Afficher moins
    24 min
Aucun commentaire pour le moment